MARATTO

article · Biomedical Chromatography

GC/MS Analysis of the Chemical Composition of Petroleum Ether and Chloroform Extracts From <scp><i>Coffea arabica</i></scp> Seeds, Along With Molecular Docking Evaluation of the Extracts Antibacterial and Anticancer Activities

Abstract

ABSTRACT The purpose of this work was to use molecular docking techniques to examine the chemical makeup and biological activity of the petroleum ether and chloroform extracts (SPEE and CHSE, respectively) of Coffee arabica seeds. According to the GC/MS results of SPEE, the extract contains 28 components, which account for approximately 96% of the total. These substances fall under several categories of phytoconstituents. Nevertheless, the extract contains 28 compounds, which make up 99.1% of the total, according to the CHSE GC/MS data. Alcohols (4.93%) with 2‐ethyl‐1‐hexanol as the primary compound, monoterpenes (3.95%) with 4‐ethyl‐1‐octyn‐3‐ol accounting for 2.92%, aromatics (2.67%), esters (38.31%) with methyl palmitate as the primary (16.71%), caffeine (28.81%), hydrocarbons (10.85%) with 7‐octadecene as the primary compound, and ketones (5.13%) with 2‐ethyl‐1‐cyclohexanone as the primary (3.04%) are among them. Only Bacillus subtilis was susceptible to the modest antibacterial activity of both extracts. Whereas CHSE successfully targeted breast (IC 50 = 146.10 μg/mL) and colon cancer cells (IC 50 = 111.90 μg/mL), SPEE showed strong cytotoxicity against hepatocellular carcinoma (IC 50 = 42.41 μg/mL) and breast cancer cells (IC 50 = 57.76 μg/mL) in anticancer studies.

Research topics

  • Coffee research and impacts
  • Tea Polyphenols and Effects
  • Coconut Research and Applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/bmc.70132

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.